Zhejiang, China

Chunrong Feng

This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Zhejiang Hisun Pharmaceutical Co., Ltd.. Active years: 2017-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chunrong Feng. Retrieved from https://idiyas.com/inventor/chunrong-feng

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0


 

Average Co-Inventor Count = 3.4

ph-index = 1


Company Filing History:


Years Active: 2017-2023

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Chunrong Feng

Introduction

Chunrong Feng is a notable inventor based in Zhejiang, China. He has made significant contributions to the field of pharmaceuticals, holding two patents that showcase his innovative spirit and technical expertise.

Latest Patents

Feng's latest patents include the HS-25 tablet and its preparation method. The HS-25 tablet is created using HS-25 and excipients through a process of wet granulation, drying, granulating, and tablet pressing. Another important patent is the HPPH lyophilized powder injection, which includes a preparation method. This injection contains HPPH, auxiliary solvents, solubilizing agents, excipients, and pH adjusting agents. The HPPH lyophilized powder injection is characterized by its loose consistency, good resolubility, low moisture content, and excellent stability.

Career Highlights

Chunrong Feng is currently associated with Zhejiang Hisun Pharmaceutical Co., Ltd., where he continues to develop innovative pharmaceutical solutions. His work has contributed to advancements in drug formulation and delivery systems.

Collaborations

Feng collaborates with talented professionals in his field, including Li Ding and Jun Dai, who contribute to his research and development efforts.

Conclusion

Chunrong Feng's contributions to pharmaceutical innovations through his patents reflect his dedication to improving healthcare solutions. His work continues to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…